Free Trial

Kooth (KOO) Competitors

Kooth logo
GBX 168.25 -0.25 (-0.15%)
(As of 11:26 AM ET)

KOO vs. INS, RENX, COG, INHC, IQAI, FDBK, DVRG, TRLS, SENS, and EMIS

Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.

Kooth vs.

Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations.

In the previous week, Kooth had 1 more articles in the media than Instem. MarketBeat recorded 1 mentions for Kooth and 0 mentions for Instem. Kooth's average media sentiment score of 0.35 beat Instem's score of 0.00 indicating that Kooth is being referred to more favorably in the media.

Company Overall Sentiment
Kooth Neutral
Instem Neutral

Kooth has higher earnings, but lower revenue than Instem. Kooth is trading at a lower price-to-earnings ratio than Instem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£54.17M1.11£4.28M£0.121,377.08
Instem£61.63M3.24£3.34M£0.145,928.57

Instem received 83 more outperform votes than Kooth when rated by MarketBeat users. However, 90.91% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote.

CompanyUnderperformOutperform
KoothOutperform Votes
10
90.91%
Underperform Votes
1
9.09%
InstemOutperform Votes
93
52.25%
Underperform Votes
85
47.75%

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 23.83% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth7.89% 23.83% 10.12%
Instem 5.50%6.35%4.62%

Kooth currently has a consensus target price of GBX 585, indicating a potential upside of 254.01%. Given Kooth's stronger consensus rating and higher probable upside, research analysts plainly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Kooth has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.

65.0% of Kooth shares are owned by institutional investors. Comparatively, 65.9% of Instem shares are owned by institutional investors. 17.3% of Kooth shares are owned by company insiders. Comparatively, 30.0% of Instem shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Kooth beats Instem on 11 of the 18 factors compared between the two stocks.

Get Kooth News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£60.28M£226.00M£5.14B£1.40B
Dividend YieldN/A6.58%4.81%11.74%
P/E Ratio1,377.08763.46135.301,558.04
Price / Sales1.11272.671,186.56311,012.94
Price / Cash5.4238.9340.4232.94
Price / Book2.394.584.872.85
Net Income£4.28M-£4.83M£118.61M£152.80M
7 Day Performance-1.64%-1.50%15.32%18.96%
1 Month Performance1.38%9.54%15.26%18.69%
1 Year Performance-44.85%22.60%34.42%23.73%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
2.4081 of 5 stars
GBX 168.25
-0.1%
GBX 585
+247.7%
N/A£61.38M£54.17M1,404.17478News Coverage
Positive News
INS
Instem
N/AGBX 830
flat
N/A+0.0%£199.62M£61.63M5,928.57500News Coverage
RENX
Renalytix
N/AGBX 9.75
+6.6%
N/A-41.0%£16.18M£2.29M-40.63102Positive News
Gap Up
High Trading Volume
COG
Cambridge Cognition
N/AGBX 30.05
-4.3%
N/A-43.7%£12.60M£13.08M-758.3380Insider Trade
News Coverage
High Trading Volume
INHC
Induction Healthcare Group
N/AGBX 8.67
-8.7%
N/A-63.1%£8.14M£13.65M-316.6774Gap Down
IQAI
IQ-AI
N/AGBX 1.47
-2.0%
N/A-61.6%£3.26M£538,190.00-13.676Gap Up
FDBK
Feedback
N/AGBX 17.35
-4.9%
N/A-76.4%£2.31M£1.18M-71.0024Gap Down
DVRG
DeepVerge
N/AGBX 0.15
flat
N/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.58
-3.3%
N/A-85.1%£937,000.00£35,000.00-20.0031Gap Down
High Trading Volume
SENS
Sensyne Health
N/AGBX 0.35
-33.3%
N/A+0.0%£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AGBX 1,920
flat
N/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools


This page (LON:KOO) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners